EN | FR
EN | FR
Search

PCLS:
An ex-vivo Window Into Lung Disease
And Drug Discovery

Precision-Cut Lung Slices (PCLS) have emerged as an innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses.

By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in vitro cell cultures and the complexities of in vivo animal models. The versatility and precision of this technique have positioned PCLS as an invaluable tool in advancing our understanding of respiratory diseases and accelerating the discovery of novel treatments.

Key Applications of PCLS in Lung Research

PCLS are widely used to investigate various aspects of lung disease, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, lung cancer, and rare diseases like pulmonary arterial hypertension. By maintaining the lung’s natural 3D structure and cellular diversity, PCLS allow researchers to explore the dynamic processes of lung function and disease pathogenesis in real time.

Disease Applications at a Glance

Disease AreaHow PCLS is Utilized
Asthma & COPDSimulating airway reactivity, constriction, and relaxation responses to stimuli.
Pulmonary Fibrosis (IPF)Exploring fibrotic pathways, identifying biomarkers, and screening antifibrotics.
Lung CancerStudying natural tumor microenvironments and complex cancer cell behavior.
Infectious DiseasesEvaluating viral/bacterial pathogenesis, immune responses, and antimicrobials.

Studying Airway Reactivity

PCLS can be used to study airway reactivity—how the airways contract and relax in response to different stimuli. This is particularly valuable for understanding diseases like asthma and COPD, where the airways become overly sensitive and prone to constriction. Researchers can expose PCLS to allergens or bronchoconstrictors to simulate these conditions, allowing them to observe how the airways respond to different therapeutic interventions.

Investigating Fibrotic Diseases

Additionally, PCLS have become a critical tool for studying fibrotic diseases like idiopathic pulmonary fibrosis (IPF). In IPF, the lung tissue becomes progressively scarred and stiff. Using PCLS from both healthy and fibrotic lungs, researchers can map the cellular pathways that drive fibrosis. This helps scientists better understand the molecular mechanisms underlying the disease and develop more effective antifibrotic treatments.

A Versatile Platform for Preclinical Drug Discovery

The versatility of PCLS extends heavily into preclinical drug discovery. Because PCLS closely mimic the natural human and animal lung environments, they are ideal for screening new drugs for lung diseases.

Researchers can utilize PCLS to assess:

  • Drug safety and toxicity

  • Therapeutic efficacy

  • Potential side effects at the cellular and molecular levels

Viral Infections and COVID-19

During the COVID-19 pandemic, PCLS were heavily utilized to investigate how SARS-CoV-2 infects lung tissue and triggers inflammation. Researchers used PCLS to evaluate potential antiviral therapies and better understand the pathogenesis of the disease in intact lung tissue. These studies provided critical insights into immune responses to viral infections and highlighted new therapeutic targets.

Oncology and Lung Cancer

Beyond viral infections, PCLS are transforming lung cancer research. Lung cancer remains one of the most lethal cancers worldwide, and traditional 2D cell cultures often fail to replicate the complexity of tumor growth and metastasis. By using PCLS derived from lung cancer patients, researchers can study cancer cell behavior in a highly natural context. This allows for the testing of potential cancer therapies and the investigation of the tumor microenvironment in a way that closely mirrors the actual in vivo situation.

Advancing Lung Health and Antimicrobial Development

PCLS have opened new avenues for studying severe respiratory pathogens, including difficult-to-treat bacteria like Pseudomonas aeruginosa and Mycobacterium tuberculosis.

These pathogens are notoriously hard to study in traditional models because they interact with multiple cell types within the lung tissue. PCLS overcome this limitation by allowing for the examination of these complex, multi-cellular interactions.

Benefits for Infectious Disease Research:

  • Provides a holistic view of how infections progress.

  • Shows exactly how the lung’s native defense mechanisms are activated.

  • Serves as a robust testing ground for new antimicrobial therapies, helping to combat the growing global crisis of antibiotic resistance.

Conclusion

Precision-Cut Lung Slices represent a true breakthrough in the study of respiratory diseases and preclinical drug discovery. By preserving the structural and functional integrity of lung tissue, PCLS provide researchers with a highly accurate ex vivo model for studying the complexities of lung pathophysiology. As their adoption continues to grow, PCLS will undoubtedly play a foundational role in speeding up the discovery of new, life-saving treatments for asthma, COPD, pulmonary fibrosis, cancer, and infectious diseases.

Reference

Related Product

Resources

PCLS Resource Hub

Our comprehensive PCLS Resource Hub is designed to support researchers by offering a robust collection of tools, data, and literature specific to PCLS applications. Whether you’re investigating lung biology, evaluating potential therapies, or looking for detailed methodologies, our resource hub is tailored to meet your research needs. Here, you’ll find curated PCLS-focused events, protocols, publications, and insights into the physioLens PCLS platform.

Empowering researchers

Welcome to SCIREQ’s knowledge center. You can find everything from software registration to document downloads to complete list of SCIREQ publications in this section. Everything you need to get the most out of your SCIREQ system.